Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TACR3 | P29371 | 12/20 | 0.44 |
| ▸ | TACR2 | P21452 | 7/20 | 0.44 |
| ▸ | KCNH2 | Q12809 | 3/20 | 0.39 |
| ▸ | OPRM1 | P35372 | 5/20 | 0.38 |
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4667073 | 0.93 | TACR3 (0.40) | TACR3TACR2KCNH2OPRM1LMNA | |
| SCHEMBL4665925 | 0.93 | TACR3 (0.40) | TACR3TACR2KCNH2OPRM1LMNA | |
| SCHEMBL4667068 | 0.89 | TACR3 (0.41) | TACR3TACR2KCNH2OPRM1LMNA | |
| SCHEMBL4665870 | 0.86 | TACR3 (0.38) | TACR3TACR2KCNH2LMNA | |
| SCHEMBL4667103 | 0.83 | TSHR (0.47) | TACR3TACR2KCNH2LMNA | |
| SCHEMBL27724853 | 0.82 | TACR3 (0.64) | TACR3TACR2KCNH2OPRM1 | |
| SCHEMBL4668627 | 0.80 | OPRM1 (0.41) | TACR3OPRM1 | |
| SCHEMBL4667024 | 0.80 | AGER (0.40) | TACR3TACR2OPRM1LMNAPOLB | |
| SCHEMBL4667476 | 0.80 | TACR3 (0.41) | TACR3KCNH2 | |
| SCHEMBL4665287 | 0.79 | FNTA (0.39) | TACR3LMNAALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1940795-A1 | N-OXO-HETEROCYCLE AND N-OXO-ALKYL QUINOLINE-4-CARBOXAMIDES AS NK-3 RECEPTOR LIGANDS | AstraZeneca AB (SE) | 2008-07-09 | — | — | EP | claimed |
| WO-2007035156-A1 | N-OXO-HETEROCYCLE AND N-OXO-ALKYL QUINOLINE-4-CARBOXAMIDES AS NK-3 RECEPTOR LIGANDS | ASTRAZENECA AB (SE) | 2007-03-29 | — | — | WO | claimed |